Traws Pharma, Inc. (TRAW)

NASDAQ

$0.56

$+0.02

(+3.39%)

Previous Close: ⁦$0.55⁩

Market Closed

Traws Pharma, Inc. (TRAW) Live Price Chart

Last updated: ⁦2026-10-03 15:22:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Traws Pharma, Inc. (TRAW) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.56, with a market capitalization of $8.38M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.43 to $3.27. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$8.38M
Open	$0.56
Day's High	$24.75
Day's Low	$0.43
Previous Close	$0.55
Volume	65.59K
Average Volume	577.69K
P/E Ratio	--
52-Week High	$3.27
52-Week Low	$0.43
Dividend Yield	--
Earnings Date	--

Traws Pharma, Inc. (TRAW) Latest Closing Stock Price

Traws Pharma, Inc. (TRAW) last closed at $0.55 as of 2026-10-02 23:40:00, unchanged from the previous close of $0.55.

During the latest regular trading session, TRAW traded between $0.43 and $24.75, with a volume of 65.59K shares. The closing price was near the lower end and near the lower end of its 52-week range.

Traws Pharma, Inc. (TRAW) 7-Day Stock Price Change

Over the past seven days, Traws Pharma, Inc. (TRAW) moved from $0.56 to $0.56, representing a gain of 0.54% ($0.00).

The stock traded between $0.50 and $0.70 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.

The average daily volume was 4.33 million shares, up versus the previous seven-day period, indicating higher trading activity.

TRAW 52-Week Price Position

Position in Range: 4.7%

52W Low$0.43

52W High$3.27

TRAW is currently trading at $0.56, placing it 4.7% of the way from its 52-week low of $0.43 to its 52-week high of $3.27. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Traws Pharma, Inc. (TRAW)?

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib. The company has four clinical programs: (i) tivoxavir marboxil, (ii) ratutrelvir, (iii) narazaciclib (ON 123300), and (iv) rigosertib. It is focused on the development of tivoxavir marboxil and ratutrelvir. The company derives revenue from its collaboration and licensing agreements.

Traws Pharma, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	7
Exchange	NASDAQ
Company Website	https://www.trawspharma.com

How to Buy Traws Pharma, Inc. (TRAW) Stock on MEXC

Eligible investors can buy real shares of Traws Pharma, Inc. (TRAW) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TRAW and Place Your Order

Open the RealStocks trading page and search for TRAW. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Traws Pharma, Inc. (TRAW) stock price today?

Traws Pharma, Inc. (TRAW) is currently trading at $ 0.56, up 3.25% ($0.02) from the previous close of $ 0.55. Intraday prices update in real time during regular trading hours.

2.Is TRAW stock going up or down today?

As of 2026-10-02 23:40:00, TRAW is trading at $ 0.56, up 3.25% ($0.02) from its previous close of $ 0.55. The stock has traded between $ 0.43 and $ 24.75 during today’s regular session. Past price movements do not guarantee future results.

3.What is TRAW pre-market price?

As of 2026-10-02 23:40:00, TRAW is trading at $ 0.55 in pre-market trading, down 0.06% ($0.00) from the previous close of $ 0.55. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TRAW after-hours price?

As of 2026-10-02 23:40:00, TRAW is trading at $ 0.56 in after-hours trading, up 2.33% ($0.01) from the regular-session close of $ 0.55. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TRAW stock trading now?

TRAW trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TRAW sit relative to its 52-week high and low?

Over the past 52 weeks, TRAW has traded between a low of $ 0.43 and a high of $ 3.27. At $ 0.56, the stock is positioned 4.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Traws Pharma, Inc. in?

Traws Pharma, Inc. (TRAW) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Traws Pharma, Inc.'s market capitalization and where is it listed?

Traws Pharma, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 8.38M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TRAW valued in terms of P/E ratio and EPS?

TRAW trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.09. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Traws Pharma, Inc. pay a dividend?

Traws Pharma, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.